Woodline Partners »

Newamsterdam Pharma Co Nv shares owned by Woodline Partners

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 1.2M 16.60
2024-06-30 $9.3M 483k 19.21

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
BVF
Woodline Partners
Jennison Associates
Henderson Group
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management

View all funds holding Newamsterdam Pharma Co Nv